The drug possessing antagonistic action at histamine, serotonin and muscarinic receptors is:
**Core Concept**
The question is testing the pharmacological principle of polyvalent antagonism, where a drug simultaneously blocks the action of multiple neurotransmitters or receptors. In this case, the receptors in question are histamine, serotonin, and muscarinic receptors, which are involved in various physiological processes including vasodilation, smooth muscle contraction, and glandular secretion.
**Why the Correct Answer is Right**
The correct answer is a drug that acts as a non-selective antagonist at these receptors, thereby counteracting their effects. This is typically achieved through a drug with a polybasic structure that can bind to multiple receptor subtypes. The specific drug in question has been used in the treatment of various conditions, including anaphylaxis, asthma, and allergic rhinitis.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not possess antagonistic action at histamine, serotonin, and muscarinic receptors. Instead, it is a selective antagonist of a different receptor subtype.
* **Option B:** This option is incorrect because it is a partial agonist at one of the receptor subtypes, rather than a full antagonist.
* **Option C:** This option is incorrect because it is a selective agonist at one of the receptor subtypes, rather than a non-selective antagonist.
**Clinical Pearl / High-Yield Fact**
This drug is often used in the treatment of anaphylaxis, but its use requires careful consideration of potential side effects, including dry mouth, blurred vision, and urinary retention.
**Correct Answer:** D. Ranitidine